X
20
Dcs Pharma Ag Basel Ch, based in Switzerland, is a pharmaceutical company.
One of their significant offerings is Bromazepam, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2005-073 - Rev 01
This Chemical Type CEP, issued on March 03, 2016, remains in force until April 25, 2017, ensuring its reliability within the pharmaceutical industry.
Substance Number 879 associated with this CEP further emphasizes